[Cellular immune response to mycobacterial antigens]. 1998

D Ordway, and M F Moraes, and L Oliveira, and R Badura, and M N Pinheiro, and J M Graça, and L Carvalho, and T Saldanha, and P Abecasis, and F A Ventura
Centro de Malária e Outras Doenças Tropicais/IHMT e Hospital Egas Moniz, Lisboa.

The authors studied the immunological response before and after beginning anti-tuberculous therapy, of a previously health, HIV negative, 22 year old black male, from the Republic of Cape Verde. The patient had multiple vertebral bony lesions associated to subcutaneous abscesses. As immunological markers of antigen recognition, we measured blastogenic and cytotoxic responses and gamma-IFN secretion towards 30 kD, 65 kD, filtrate proteins of M. tuberculosis, M. tuberculosis (H37Rv) and PPD cultures. To characterise the role of cytokines during infection, expression of mRNA for gamma-IFN, IL-4 and IL-10 was also analysed. A slight increase of lymphocyte proliferation and gamma-IFN production was seen in response to purified protein derivative (PPD) and short term culture filtrate proteins (ST-CFP), after one month of therapy. More significant, was the increase in M. tuberculosis and PPD-specific cytolytic T lymphocyte response after one one month of treatment. After 6 months of treatment, blastogenic and cytotoxic responses and gamma-IFN production were considerably higher toward the antigen panel. The CD4/CD8 ratio increased from 0.7 to 1.4 after treatment. We observed that ST-CFP and MT-CFP induced increasingly higher lymphoproliferation and gamma-IFN production, confirming their role in the protective immune responses to M. tuberculosis. The reduced immune responses in the peripheral blood of this patient probably reflect a high activity in the local sites of infection. This case of disseminated tuberculosis infection maybe related to nutritional or social factors or may represent an example of reduced in ate resistance against tuberculosis infection.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008297 Male Males
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014374 Tuberculin Test One of several skin tests to determine past or present tuberculosis infection. A purified protein derivative of the tubercle bacilli, called tuberculin, is introduced into the skin by scratch, puncture, or interdermal injection. Test, Tuberculin,Tests, Tuberculin,Tuberculin Tests
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

D Ordway, and M F Moraes, and L Oliveira, and R Badura, and M N Pinheiro, and J M Graça, and L Carvalho, and T Saldanha, and P Abecasis, and F A Ventura
December 1994, Lancet (London, England),
D Ordway, and M F Moraes, and L Oliveira, and R Badura, and M N Pinheiro, and J M Graça, and L Carvalho, and T Saldanha, and P Abecasis, and F A Ventura
September 1999, Clinical and experimental immunology,
D Ordway, and M F Moraes, and L Oliveira, and R Badura, and M N Pinheiro, and J M Graça, and L Carvalho, and T Saldanha, and P Abecasis, and F A Ventura
February 2000, Human immunology,
D Ordway, and M F Moraes, and L Oliveira, and R Badura, and M N Pinheiro, and J M Graça, and L Carvalho, and T Saldanha, and P Abecasis, and F A Ventura
May 1974, Canadian journal of microbiology,
D Ordway, and M F Moraes, and L Oliveira, and R Badura, and M N Pinheiro, and J M Graça, and L Carvalho, and T Saldanha, and P Abecasis, and F A Ventura
September 1980, Transplantation proceedings,
D Ordway, and M F Moraes, and L Oliveira, and R Badura, and M N Pinheiro, and J M Graça, and L Carvalho, and T Saldanha, and P Abecasis, and F A Ventura
December 1995, Clinical and experimental immunology,
D Ordway, and M F Moraes, and L Oliveira, and R Badura, and M N Pinheiro, and J M Graça, and L Carvalho, and T Saldanha, and P Abecasis, and F A Ventura
October 1991, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
D Ordway, and M F Moraes, and L Oliveira, and R Badura, and M N Pinheiro, and J M Graça, and L Carvalho, and T Saldanha, and P Abecasis, and F A Ventura
September 1986, Infection and immunity,
D Ordway, and M F Moraes, and L Oliveira, and R Badura, and M N Pinheiro, and J M Graça, and L Carvalho, and T Saldanha, and P Abecasis, and F A Ventura
September 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
D Ordway, and M F Moraes, and L Oliveira, and R Badura, and M N Pinheiro, and J M Graça, and L Carvalho, and T Saldanha, and P Abecasis, and F A Ventura
January 2004, Problemy tuberkuleza i boleznei legkikh,
Copied contents to your clipboard!